Please Share! Thanks!

facebook.com/share/v/QqMHhX…

PARP inhibitors have greatly improved survival for #breastcancer patients with BRCA1/2 mutations, but so far, have not been durable. A new Columbia study is the first to identify a way to keep PARP inhibitors' potency with an existing drug 💊 cuimc.columbia.edu/news/study-sug…

To honor #NationalNonprofitDay, we asked some of our community members why volunteering with LLS is important to them and what ripple effects they've experienced from getting involved. Read more on our latest blog ➡️ msg.lls.org/3yIIIBW

instagram.com/p/C-2aWHfuxa7/…

2021 June Edition ciscrp.org/portfolio/2021…

Just published! With Kelly Norsworthy, MD and other FDA authors Ashley Woods, R. Angelo de Claro, Marc R. Theoret and E. Dianne Pulte. #OCEPublications

winshipcancer.emory.edu/newsroom/artic…

All groundbreaking #CancerResearch discoveries start with an idea that needs funding to be put into action. Learn how to apply for a research grant through NCI. spr.ly/6017lqYJv

Today, NCI released its latest Annual Plan & Budget Proposal. It presents our assessment of the optimal funding needed to support the #CancerResearch enterprise and, ultimately, to help all people live longer, healthier lives. Read more. go.nih.gov/mtWNQUt #NCIFuture

“Vera couldn’t put on clothes without having panic attacks, which meant we were going to the hospital. Her separation anxiety was suffocating, sending her into fight or flight mode if anyone left the house.” - Vera, 5, B-cell acute lymphoblastic leukemia survivor. Read her story

Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia 🌷doi.org/10.5045/br.202… Blood Res 2023; 58(S1):Jae Joon Han #Chronic_myeloid_leukemia #Dasatinib #Nilotinib #Imatinib #Treatment_free_remission

September is Sickle Cell Awareness Month. This chronic blood disorder affects millions worldwide, and a bone marrow transplant is currently the only known cure. At the Icla da Silva Foundation, we're committed to helping patients receive transplants to cure sickle cell.

👏 The #CML session is underway at #SOHO2024! 🎙️ BCT Associate Editor Jerry Radich, MD, of Fred Hutchinson Cancer Center, takes the podium to discuss allografting for CML. ➡️bloodcancerstoday.com/conference/twe…

OHSU researchers detail their methodology in utilizing new drug combinations on a patient with #CML who acquired a highly resistant BCR-ABL1 compound mutation: now.ohsu.edu/member/post/oh…

Investigators supported by the NCI Division of Cancer Biology share how their fundamental scientific discoveries led to important breakthroughs in #CancerResearch. go.nih.gov/y3o910P #Every1HasARole

The participant makeup of many current trials is not accurately representative of real-world populations. This recent article tackles this and other pressing issues around creating more inclusive research. ow.ly/EGZ150Tfvzu #clinicalresearch #clinicaltrials

At the Society of Hematologic #Oncology 2024 meeting, experts discussed new perspectives in the management of chronic myeloid #leukemia (#CML), including adapting personalized approaches and adaptive strategies to optimize patient care. #SOHO Learn more: bit.ly/47xlZG9

🔥 Check out the randomized #SolidarityFinland #imatinib trial 🇫🇮 poster today at 1230 at #ERS2024 meeting 🇦🇹 🌟 Presenting the first author, @HelsinkiUni medical & doctoral student @HalmeAlex 📢 Full text open access at sciencedirect.com/science/articl… #COVID #EBM #LongCovid #RCT

Here's what you need to know about #Leukemia. #ACancerFreeAfrica #BecauseWeCare